2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- PMID: 34895950
- DOI: 10.1016/j.jacc.2021.09.006
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Erratum in
-
Correction.J Am Coll Cardiol. 2022 Apr 19;79(15):1547. doi: 10.1016/j.jacc.2022.03.330. J Am Coll Cardiol. 2022. PMID: 35422252 No abstract available.
-
Correction.J Am Coll Cardiol. 2024 Aug 20;84(8):771. doi: 10.1016/j.jacc.2024.07.010. J Am Coll Cardiol. 2024. PMID: 39142733 No abstract available.
Abstract
Aim: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use.
Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered.
Structure: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients' interests.
Keywords: ACC/AHA Clinical Practice Guidelines; angiogram; angiography; angioplasty; arterial graft; cardiac surgery; coronary artery bypass graft surgery; coronary atherosclerosis; internal mammary artery graft; internal thoracic artery graft; left ventricular dysfunction; multivessel PCI; myocardial infarction; myocardial revascularization; non–ST-segment–elevated myocardial infarction; percutaneous coronary intervention; percutaneous transluminal coronary angioplasty; post-bypass; saphenous vein graft; stent(s); vein graft lesions.
Copyright © 2022 The American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
The American Association for Thoracic Surgery and The Society of Thoracic Surgeons Reasoning for Not Endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines.Ann Thorac Surg. 2022 Apr;113(4):1065-1068. doi: 10.1016/j.athoracsur.2021.12.003. Epub 2021 Dec 23. Ann Thorac Surg. 2022. PMID: 34954249 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous